DOCSLIB.ORG

TRPA1 in Inflammation Acta Universitatis Tamperensis 2173

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TRPA1 in Inflammation Acta Universitatis Tamperensis 2173 LAURI MOILANEN TRPA1 in Inflammation TRPA1 LAURI MOILANEN Acta Universitatis Tamperensis 2173 LAURI MOILANEN TRPA1 in Inflammation AUT 2173 AUT LAURI MOILANEN TRPA1 in Inflammation ACADEMIC DISSERTATION To be presented, with the permission of the Board of the School of Medicine of the University of Tampere, for public discussion in the small auditorium of building B, School of Medicine, Medisiinarinkatu 3, Tampere, on 10 June 2016, at 12 o’clock. UNIVERSITY OF TAMPERE LAURI MOILANEN TRPA1 in Inflammation Acta Universitatis Tamperensis 2173 Tampere University Press Tampere 2016 ACADEMIC DISSERTATION University of Tampere, School of Medicine Tampere University Hospital National Doctoral Programme of Musculoskeletal Disorders and Biomaterials (TBDP) Finland Supervised by Reviewed by Docent Riina Nieminen Docent Paula Rytilä University of Tampere University of Helsinki Finland Finland Professor Lauri Lehtimäki Professor Ulf Simonsen University of Tampere Aarhus University Finland Denmark Professor Eeva Moilanen University of Tampere Finland The originality of this thesis has been checked using the Turnitin OriginalityCheck service in accordance with the quality management system of the University of Tampere. Copyright ©2016 Tampere University Press and the author Cover design by Mikko Reinikka Distributor: [email protected] https://verkkokauppa.juvenes.fi Acta Universitatis Tamperensis 2173 Acta Electronica Universitatis Tamperensis 1672 ISBN 978-952-03-0131-6 (print) ISBN 978-952-03-0132-3 (pdf) ISSN-L 1455-1616 ISSN 1456-954X ISSN 1455-1616 http://tampub.uta.fi Suomen Yliopistopaino Oy – Juvenes Print Tampere 2016 441 729 Painotuote To my close ones. Contents List of Original Communications ..................................................................................... 9 Abbreviations ..................................................................................................................... 10 Abstract ............................................................................................................................... 11 Tiivistelmä ........................................................................................................................... 13 Introduction ....................................................................................................................... 15 1 Review of the Literature .......................................................................................... 19 1.1 Transient Receptor Potential Ion Channels ................................................. 19 1.2 TRPA1 ............................................................................................................... 23 1.2.1 Trpa1 Gene and Protein Structure ....................................................... 23 1.2.2 TRPA1 Expression ................................................................................. 25 1.2.3 TRPA1 Electrophysiology ..................................................................... 26 1.2.4 Exogenous Chemical Activators of TRPA1 ....................................... 27 1.2.5 Endogenous Chemical Activators of TRPA1 ..................................... 29 1.2.6 Activation of TRPA1 by Cold and Mechanical Stimuli ..................... 30 1.2.7 Blockers of TRPA1 ................................................................................. 31 1.2.8 Physiological Function of TRPA1 ........................................................ 32 1.2.9 Non-Neuronal TRPA1 ........................................................................... 34 1.2.10 TRPA1 in Pain ......................................................................................... 34 1.2.11 TRPA1 in Inflammation ........................................................................ 39 1.3 Inflammation .................................................................................................... 40 1.4 Carrageenan-Induced Acute Paw Inflammation ......................................... 42 1.5 Gout ................................................................................................................... 43 1.6 Monosodium Urate-Induced Experimental Gout ...................................... 44 1.7 Osteoarthritis .................................................................................................... 45 1.8 Monosodium Iodoacetate-Induced Experimental Osteoarthritis and Inflammation ..................................................................................................... 46 1.9 Allergic Inflammation ...................................................................................... 48 1.10 Ovalbumin-Induced Experimental Allergic Inflammation ........................ 50 1.11 Pinosylvin ........................................................................................................... 51 2 Aims of the Study ...................................................................................................... 52 3 Materials and Methods ............................................................................................. 53 3.1 Compounds ....................................................................................................... 53 3.2 Mice .................................................................................................................... 53 3.3 Acute Paw Edema ............................................................................................ 55 3.4 Monosodium Urate-Induced Acute Arthritis............................................... 55 3.5 Monosodium Urate-Induced Air-Pouch Inflammation ............................. 56 3.6 Monosodium Iodoacetate-Induced Osteoarthritis ...................................... 56 3.7 Ovalbumin-Induced Conjunctivitis ............................................................... 57 3.8 Cell and Cartilage Culture ............................................................................... 58 3.8.1 HEK 293 Cells ......................................................................................... 58 3.8.2 Human Osteoarthritic Chondrocytes ................................................... 59 3.8.3 Mouse Cartilage Culture ......................................................................... 59 3.8.4 Eosinophil Isolation, Culture and Viability Determination .............. 59 3.8.5 Splenocyte Isolation and Interleukin-13 Measurements .................... 61 3.9 Protein Extraction and Western Blotting ..................................................... 61 3.10 Enzyme Linked Immunosorbent Assay ....................................................... 62 3.11 RNA Extraction and Reverse Transcription Polymerase Chain Reaction .. ............................................................................................................................. 62 3.12 Patch Clamp, Fura-2-AM and Fluo-3-AM Measurements ........................ 64 3.12.1 Patch Clamp Measurements ................................................................... 64 3.12.2 Fura-2-AM Measurements ..................................................................... 64 3.12.3 Fluo-3-AM Measurements ..................................................................... 65 3.13 Statistics .............................................................................................................. 65 4 Summary of Results .................................................................................................. 66 4.1 Role of TRPA1 in Carrageenan-Induced Acute Inflammation (Study I) 66 4.1.1 TRPA1 Activation Enhances Carrageenan-Induced Paw Edema ... 66 4.1.2 TRPA1 Mediates AITC-Induced Edema in a COX-Dependent Manner ...................................................................................................... 67 4.1.3 AITC Increases COX-2 Expression in a TRPA1-Dependent Manner ...................................................................................................... 68 4.1.4 Carrageenan is not a Direct TRPA1 Activator ................................... 69 4.2 TRPA1 in Experimental MSU Crystal-induced Gouty Inflammation (Study II) ............................................................................................................ 69 4.2.1 TRPA1 Enhances MSU Crystal-Induced Gouty Inflammation ...... 69 4.2.2 TRPA1 Mediates Pain in Experimental Gouty Arthritis ................... 72 4.2.3 MSU Crystals do not Activate TRPA1 Directly ................................. 73 4.3 Involvement of TRPA1 in MIA-Induced Experimental Osteoarthritis and Inflammation (Study III) ......................................................................... 73 4.3.1 MIA-Induced Acute Inflammation is Partly Dependent on TRPA1 Activation ................................................................................................. 73 4.3.2 MIA Increases COX-2 Expression in Chondrocytes via TRPA1 ... 76 4.3.3 TRPA1 Mediates Cartilage Degeneration and Joint Pain in MIA- Induced Osteoarthritis ............................................................................ 79 4.3.4 MIA is not a Direct TRPA1 Activator ................................................. 81 4.4 TRPA1 in Ovalbumin-Induced Acute Allergic Inflammation (Study IV) .. ............................................................................................................................. 81 4.4.1 Activation of TRPA1 is Crucial in the Development of Ovalbumin- Induced Allergic Conjunctivitis ............................................................. 81 4.4.2 TRPA1 does not Affect Eosinophil
Load more

Recommended publications
  • Drying Effects on Chemical Composition and Antioxidant Activity of Lippia Thymoides Essential Oil, a Natural Source of Thymol
    molecules Article Drying Effects on Chemical Composition and Antioxidant Activity of Lippia thymoides Essential Oil, a Natural Source of Thymol Lidiane Diniz do Nascimento 1,2,* , Sebastião Gomes Silva 3 ,Márcia Moraes Cascaes 4, Kauê Santana da Costa 5,* , Pablo Luis Baia Figueiredo 6 , Cristiane Maria Leal Costa 7, Eloisa Helena de Aguiar Andrade 2,4 and Lênio José Guerreiro de Faria 1,7 1 Programa de Pós-Graduação em Engenharia de Recursos Naturais da Amazônia, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] 2 Coordenação de Botânica, Museu Paraense Emílio Goeldi, Belém 66077-830, Pará, Brazil; [email protected] 3 Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] 4 Programa de Pós-Graduação em Química, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] 5 Faculdade de Biotecnologia, Instituto de Biodiversidade, Universidade Federal do Oeste do Pará, Santarém 68035-110, Pará, Brazil 6 Departamento de Ciências Naturais, Universidade do Estado do Pará, Belém 66050-540, Pará, Brazil; pablo.fi[email protected] 7 Programa de Pós-Graduação em Engenharia Química, Universidade Federal do Pará, Belém 66075-110, Pará, Brazil; [email protected] Citation: Nascimento, L.D.d.; Silva, * Correspondence: [email protected] (L.D.d.N.); [email protected] (K.S.d.C.); S.G.; Cascaes, M.M.; Costa, K.S.d.; Tel.: +55-91-3217-6086 (L.D.d.N.); +55-93-2101-6771 (K.S.d.C.) Figueiredo, P.L.B.; Costa, C.M.L.; Andrade, E.H.d.A.; de Faria, L.J.G.
    [Show full text]
  • Retention Indices for Frequently Reported Compounds of Plant Essential Oils
    Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5.
    [Show full text]
  • 1 TRP About Online
    a TR P to Spain International Workshop on Transient Receptor Potential Channels 12th – 14th September 2012 Valencia, Spain www.trp2012.com SCHEDULE and ABSTRACTS BOOK September 2012 Dear participants, Travelling to faraway places in search of spiritual or cultural enlightenment is a millennium old human activity. In their travels, pilgrims brought with them news, foods, music and traditions from distant lands. This friendly exchange led to the cultural enrichment of visitors and the economic flourishing of places, now iconic, such as Rome, Santiago, Jerusalem, Mecca, Varanasi or Angkor Thom. The dissemination of science and technology also benefited greatly from these travels to remote locations. The new pilgrims of the Transient Receptor Potential (TRP) community are also very fond of travelling. In the past years they have gathered at various locations around the globe: Breckenridge (USA), Eilat (Israel), Stockholm (Sweden) and Leuven (Belgium) come to mind. These meetings, each different and exciting, have been very important for the dissemination of TRP research. We are happy to welcome you in Valencia (Spain) for TRP2012. The response to our call has been extraordinary, surpassing all our expectations. The speakers, the modern bards, readily attended our request to communicate their new results. At last count we were already more than 170 participants, many of them students, and most presenting their recent work in the form of posters or short oral presentations. At least 25 countries are sending TRP ambassadors to Valencia, making this a truly international meeting. We like to thank the staff of the Cátedra Santiago Grisolía, Fundación Ciudad de las Artes y las Ciencias for their dedication and excellence in handling the administrative details of the workshop.
    [Show full text]
  • Advancing Basic Pain Research
    The Rita Allen Foundation AWARD IN PAIN SCHOLARS: ADVANCING BASIC PAIN RESEARCH AWARD IN PAIN SCHOLARS: ADVANCING BASIC PAIN RESEARCH 1 COVER: Tuan Trang, a 2014 Rita Allen Foundation Scholar, has investigated mechanisms of opioid tolerance and withdrawal. Trang and his research group have found that immune cells in the central nervous system, known as microglia, play a key role in the development of morphine tolerance in an animal model. This image, a compilation of spinal microglia forming a cross section of the lumbar spinal cord, appeared on the cover of the October 18, 2017, issue of The Journal of Neuroscience in conjunction with the research article “Site-Specific Regulation of P2X7 Receptor Function in Microglia Gates Morphine Analgesic Tolerance.” (Image by Heather Leduc-Pessah, Trang Laboratory) A NETWORK OF HOPE Created in 2009 to expand the reach of the Rita Allen Foundation Scholars program, the Award in Pain has now supported 29 pioneering early-career Pain Scholars. Each year, as we welcome our newest class of Scholars, we reflect on the accomplishments of this growing community of researchers and the profound questions that drive them forward to new discoveries. These scientists are leading efforts to understand the complex neurobiological mechanisms that underlie pain—including mapping the neural circuits of chronic pain, defining the Elizabeth G. Christopherson roles of immune signals, and examining the connections President and between pain and itch. Their findings point to approaches for Chief Executive Officer combating opioid tolerance and withdrawal, interventions Rita Allen Foundation to interrupt the transition from acute to chronic pain after injury, and targets for completely novel pain therapies with the potential to improve safety and specificity.
    [Show full text]
  • Methylcyclopentanone Condensed with Methyl Vinyl Ketone to Give the Dione
    In presenting the dissertation as a partial fulfillment of the requirements for an advanced degree from the Georgia Institute of Technology, I agree that the Library of the Institute shall make it available for inspection and circulation in accordance with its regulations governing materials of this type. I agree that permission to copy from, or to publish from, this dissertation may be granted by the professor under whose direction it was written, or, in his absence, by the Dean of the Graduate Division when such copying or publication is solely for scholarly purposes and does not involve potential f inane ia]. gain. It is under­ stood that any copying from, or publication of, this dis­ sertation which involves potential financial gain will not be allowed without written permission. 3/17/65 PART I REACTIONS OF ENOLATES DERIVED FROM UNSYMMETRICAL CYCLIC KETONES PART n PHOTOCHEMICAL REARRANGEMENTS OF CROSS CONJUGATED CYCLOHEXADIENONES RELATED TO INDAN A THESIS Presented to The Faculty of the Graduate Division by William Joseph Powers, III In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the School of Chemistry Georgia Institute of Technology May, 1968 PART I REACTIONS OF ENOLATES DERIVED FROM UNSYMMETRICAL CYCLIC KETONES PART II PHOTOCHEMICAL REARRANGEMENTS OF CROSS CONJUGATED CYCLOHEXADIENONES RELATED TO INDAN Approved: Chairman —T, approved by Cha&limn: "JY\ 0*^ 7y 1 ii ACKNOWLEDGMENTS The author is grateful to Professor Drury S. Caine, III for suggesting these problems and for his patience and guidance throughout the course of this research. The author also wishes to thank Professors John R. Dyer and Charles L.
    [Show full text]
  • Genetic Variation As a Tool for Identifying Novel Transducers of Itch
    Genetic variation as a tool for identifying novel transducers of itch By Takeshi Morita A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Molecular and Cell Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Diana M. Bautista, Co-Chair Professor Rachel B. Brem, Co-Chair Professor John Ngai Professor Kristin Scott Professor Michael W. Nachman Summer 2016 Abstract Genetic variation as a tool for identifying novel transducers of itch by Takeshi Morita Doctor of Philosophy in Molecular and Cell Biology University of California, Berkeley Professor Diana M. Bautista, Co-Chair Professor Rachel B. Brem, Co-Chair The mammalian somatosensory system mediates itch, the irritating sensation that elicits a desire to scratch. Millions of people worldwide suffer from chronic itch that fails to respond to current drugs and therapies. Even though recent studies have begun to elucidate the basic characteristics of the itch circuitry, we have little understanding about the molecules and signaling mechanisms that underlie detection and transduction of itch sensation, especially during chronic itch conditions. We have taken a genomic approach by harnessing natural variation in itch-evoked scratching behaviors in mice to identify novel molecular players that are involved in itch signal transduction at the level of primary sensory neurons. From our analysis, we identified numerous candidate itch genes, and further identified a serotonin receptor, HTR7 as a key transducer that is required for both development and maintenance of chronic itch. We further investigated the genetic basis of variation in itch, and identified a set of genes and regulatory pathways that may be involved in controlling itch behaviors.
    [Show full text]
  • TRP Channel Transient Receptor Potential Channels
    TRP Channel Transient receptor potential channels TRP Channel (Transient receptor potential channel) is a group of ion channels located mostly on the plasma membrane of numerous human and animal cell types. There are about 28 TRP channels that share some structural similarity to each other. These are grouped into two broad groups: Group 1 includes TRPC ("C" for canonical), TRPV ("V" for vanilloid), TRPM ("M" for melastatin), TRPN, and TRPA. In group 2, there are TRPP ("P" for polycystic) and TRPML ("ML" for mucolipin). Many of these channels mediate a variety of sensations like the sensations of pain, hotness, warmth or coldness, different kinds of tastes, pressure, and vision. TRP channels are relatively non-selectively permeable to cations, including sodium, calcium and magnesium. TRP channels are initially discovered in trp-mutant strain of the fruit fly Drosophila. Later, TRP channels are found in vertebrates where they are ubiquitously expressed in many cell types and tissues. TRP channels are important for human health as mutations in at least four TRP channels underlie disease. www.MedChemExpress.com 1 TRP Channel Antagonists, Inhibitors, Agonists, Activators & Modulators (-)-Menthol (E)-Cardamonin Cat. No.: HY-75161 ((E)-Cardamomin; (E)-Alpinetin chalcone) Cat. No.: HY-N1378 (-)-Menthol is a key component of peppermint oil (E)-Cardamonin ((E)-Cardamomin) is a novel that binds and activates transient receptor antagonist of hTRPA1 cation channel with an IC50 potential melastatin 8 (TRPM8), a of 454 nM. Ca2+-permeable nonselective cation channel, to 2+ increase [Ca ]i. Antitumor activity. Purity: ≥98.0% Purity: 99.81% Clinical Data: Launched Clinical Data: No Development Reported Size: 10 mM × 1 mL, 500 mg, 1 g Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg (Z)-Capsaicin 1,4-Cineole (Zucapsaicin; Civamide; cis-Capsaicin) Cat.
    [Show full text]
  • UC Berkeley UC Berkeley Electronic Theses and Dissertations
    UC Berkeley UC Berkeley Electronic Theses and Dissertations Title The Effects of Neurosteroids, such as Pregnenolone Sulfate and its receptor, TrpM3 in the Retina. Permalink https://escholarship.org/uc/item/04d8607f Author Webster, Corey Michael Publication Date 2019 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California The Effects of Neurosteroids, such as Pregnenolone Sulfate, and its receptor, TrpM3 in the Retina. By Corey Webster A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Molecular and Cell Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Marla Feller, Chair Professor Diana Bautista Professor Daniella Kaufer Professor Stephan Lammel Fall 2019 The Effects of Neurosteroids, such as Pregnenolone Sulfate, and its receptor, TrpM3 in the Retina. Copyright 2019 by Corey Webster Abstract The Effects of Neurosteroids, such as Pregnenolone Sulfate, and its receptor, TrpM3 in the Retina. by Corey M. Webster Doctor of Philosophy in Molecular and Cell Biology University of California, Berkeley Professor Marla Feller, Chair Pregnenolone sulfate (PregS) is the precursor to all steroid hormones and is produced in neurons in an activity dependent manner. Studies have shown that PregS production is upregulated during certain critical periods of development, such as in the first year of life in humans, during adolescence, and during pregnancy. Conversely, PregS is decreased during aging, as well as in several neurodevelopmental and neurodegenerative conditions. There are several known targets of PregS, such as a positive allosteric modulator NMDA receptors, sigma1 receptor, and as a negative allosteric modulator of GABA-A receptors.
    [Show full text]
  • Transient Receptor Potential Channels As Drug Targets: from the Science of Basic Research to the Art of Medicine
    1521-0081/66/3/676–814$25.00 http://dx.doi.org/10.1124/pr.113.008268 PHARMACOLOGICAL REVIEWS Pharmacol Rev 66:676–814, July 2014 Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics ASSOCIATE EDITOR: DAVID R. SIBLEY Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine Bernd Nilius and Arpad Szallasi KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Ion Channel Research, Campus Gasthuisberg, Leuven, Belgium (B.N.); and Department of Pathology, Monmouth Medical Center, Long Branch, New Jersey (A.S.) Abstract. ....................................................................................679 I. Transient Receptor Potential Channels: A Brief Introduction . ...............................679 A. Canonical Transient Receptor Potential Subfamily . .....................................682 B. Vanilloid Transient Receptor Potential Subfamily . .....................................686 C. Melastatin Transient Receptor Potential Subfamily . .....................................696 Downloaded from D. Ankyrin Transient Receptor Potential Subfamily .........................................700 E. Mucolipin Transient Receptor Potential Subfamily . .....................................702 F. Polycystic Transient Receptor Potential Subfamily . .....................................703 II. Transient Receptor Potential Channels: Hereditary Diseases (Transient Receptor Potential Channelopathies). ......................................................704
    [Show full text]
  • TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities
    pharmaceuticals Review TRP Channels and Migraine: Recent Developments and New Therapeutic Opportunities Silvia Benemei 1 and Greg Dussor 2,* 1 Headache Centre, Careggi University Hospital, Viale Pieraccini 18, 50139 Florence, Italy; silvia.benemei@unifi.it 2 School of Behavioral and Brain Sciences, Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, TX 75080, USA * Correspondence: [email protected]; Tel.: +1-972-883-2385 Received: 1 March 2019; Accepted: 4 April 2019; Published: 9 April 2019 Abstract: Migraine is the second-most disabling disease worldwide, and the second most common neurological disorder. Attacks can last many hours or days, and consist of multiple symptoms including headache, nausea, vomiting, hypersensitivity to stimuli such as light and sound, and in some cases, an aura is present. Mechanisms contributing to migraine are still poorly understood. However, transient receptor potential (TRP) channels have been repeatedly linked to the disorder, including TRPV1, TRPV4, TRPM8, and TRPA1, based on their activation by pathological stimuli related to attacks, or their modulation by drugs/natural products known to be efficacious for migraine. This review will provide a brief overview of migraine, including current therapeutics and the link to calcitonin gene-related peptide (CGRP), a neuropeptide strongly implicated in migraine pathophysiology. Discussion will then focus on recent developments in preclinical and clinical studies that implicate TRP channels in migraine pathophysiology or in the efficacy of therapeutics. Given the use of onabotulinum toxin A (BoNTA) to treat chronic migraine, and its poorly understood mechanism, this review will also cover possible contributions of TRP channels to BoNTA efficacy.
    [Show full text]
  • Photoactivation of Olfactory Sensory Neurons Does Not Affect Action Potential Conduction in Individual Trigeminal Sensory Axons Innervating the Rodent Nasal Cavity
    bioRxiv preprint doi: https://doi.org/10.1101/517391; this version posted January 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Photoactivation of olfactory sensory neurons does not affect action potential conduction in individual trigeminal sensory axons innervating the rodent nasal cavity Margot Maurer1, Nunzia Papotto2, Julika Sertel-Nakajima3, Markus Schueler3, Frank Möhrlen2, Karl Messlinger3, Roberto De Col3, Stephan Frings2, Richard W Carr1 1 Experimental Pain Research, Medical Faculty Mannheim, Heidelberg University 2 Centre for Organismal Studies, Heidelberg University, Heidelberg, Germany 3 Institute for Physiology and Pathophysiology, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany Short title: Olfactory-trigeminal interactions in the nose Keywords nose; respiratory epithelium; olfactory epithelium; ethmoid nerve; chemesthesis; unmyelinated polymodal afferent Corresponding author: Richard Carr Experimental Pain Research Medical Faculty Mannheim Heidelberg University Ludolf-Krehl-Str. 13-17 68167 Mannheim Germany bioRxiv preprint doi: https://doi.org/10.1101/517391; this version posted January 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Olfactory and trigeminal chemosensory systems reside in parallel within the mammalian nose. Psychophysical studies in people indicate that these two systems interact at a perceptual level. Trigeminal sensations of pungency mask odour perception, while olfactory stimuli can influence trigeminal signal processing tasks such as odour localization.
    [Show full text]
  • The Role of Sphingosine 1-Phosphate and See the Same Effect Really Suggests That It’S an Active Process
    Dr. Diana Bautista is an Associate Professor of Cell and Developmental Biology and Affiliate of the Division PAIN of Neurobiology in the Department of Molecular and Cell Biology and the Helen Wills Neuroscience Institute at the University of California, Berkeley. Professor Bautista’s research focuses on using molecular, cellular, and physiological VERSUS approaches to investigate how humans perceive and distinguish between pain and itch. In this interview, we discuss her findings on the importance of the sphingosine ITCH: THE 1-phosphate (S1P) signaling pathway in mechanosensation. : Before we talk about how the body perceives the world, BSJhow have you perceived the world throughout your life? Did you see yourself studying somatosensation early on in your academic career? What about your path to Berkeley has surprised ROLE OF you? : I started out as a fine arts major. I took a number of DByears to figure out that I was more interested in studying S1P science as an academic pursuit and potentially as a career. As an undergraduate, when I was working in the lab, I became more interested in science and experiments. I worked in a lab that was studying basic mechanisms of phototransduction, vision, and Interview with how light gets converted into an electrical signal. I just really Professor Diana liked neuroscience and the idea that you can take something that everybody can relate to and experience and try to understand it at Bautista a molecular and cellular level—like how we perceive light. To me, that was really exciting, that something so fundamental could be looked at. As an undergraduate, in real time, I was able to shine light on a photoreceptor and record the electrical signal.
    [Show full text]